LSV Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-295,388
| Closed | -$1.65M | – | 891 |
|
|
2024
Q2 | $1.65M | Sell |
295,388
-38,770
| -12% | -$217K | ﹤0.01% | 625 |
|
|
2024
Q1 | $1.75M | Sell |
334,158
-57,600
| -15% | -$302K | ﹤0.01% | 624 |
|
|
2023
Q4 | $2.05M | Sell |
391,758
-17,000
| -4% | -$88.9K | ﹤0.01% | 617 |
|
|
2023
Q3 | $6.45M | Hold |
408,758
| – | – | 0.02% | 487 |
|
|
2023
Q2 | $7.95M | Buy |
408,758
+165,022
| +68% | +$3.21M | 0.02% | 461 |
|
|
2023
Q1 | $6.92M | Buy |
243,736
+92,318
| +61% | +$2.62M | 0.02% | 475 |
|
|
2022
Q4 | $4.43M | Buy |
+151,418
| New | +$4.43M | 0.01% | 529 |
|
|
2021
Q1 | – | Sell |
-3,289
| Closed | -$153K | – | 951 |
|
|
2020
Q4 | $153K | Sell |
3,289
-10,511
| -76% | -$489K | ﹤0.01% | 885 |
|
|
2020
Q3 | $586K | Sell |
13,800
-154,701
| -92% | -$6.57M | ﹤0.01% | 786 |
|
|
2020
Q2 | $8.08M | Sell |
168,501
-151,726
| -47% | -$7.28M | 0.02% | 471 |
|
|
2020
Q1 | $14.7M | Sell |
320,227
-48,950
| -13% | -$2.25M | 0.04% | 345 |
|
|
2019
Q4 | $22.2M | Sell |
369,177
-92,381
| -20% | -$5.55M | 0.03% | 369 |
|
|
2019
Q3 | $26.1M | Buy |
461,558
+57,189
| +14% | +$3.24M | 0.04% | 332 |
|
|
2019
Q2 | $22.5M | Buy |
404,369
+154,365
| +62% | +$8.59M | 0.04% | 359 |
|
|
2019
Q1 | $12.6M | Buy |
250,004
+166,715
| +200% | +$8.42M | 0.02% | 438 |
|
|
2018
Q4 | $3.36M | Sell |
83,289
-6,052
| -7% | -$244K | 0.01% | 617 |
|
|
2018
Q3 | $6.19M | Sell |
89,341
-503,301
| -85% | -$34.9M | 0.01% | 577 |
|
|
2018
Q2 | $44.8M | Sell |
592,642
-266,500
| -31% | -$20.2M | 0.07% | 268 |
|
|
2018
Q1 | $45.3M | Buy |
859,142
+125,320
| +17% | +$6.6M | 0.07% | 257 |
|
|
2017
Q4 | $39.2M | Buy |
733,822
+506,028
| +222% | +$27M | 0.06% | 278 |
|
|
2017
Q3 | $13.6M | Buy |
+227,794
| New | +$13.6M | 0.02% | 435 |
|